Codiak Biosciences Inc (CDAK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CDAK | BMY | MRNA | AMGN | GILD |
| Company | Codiak Biosciences Inc | Bristol-Myers Squibb Company | Moderna Inc | Amgen Inc | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.1100 | 48.68 | 102.82 | 265.91 | 67.74 |
| High | 0.1100 | 48.68 | 102.82 | 265.91 | 67.74 |
| Low | 0.0532 | 48.68 | 102.82 | 265.91 | 67.74 |
| Last | 0.0570 | 48.68 | 102.82 | 265.91 | 67.74 |
| Change | -0.0725 | +0.17 | -1.04 | +0.40 | -0.01 |
| % Change | -55.98% | +0.35% | -1.00% | +0.15% | -0.01% |
| Volume | 14,634,700 | 3,610 | 9,488 | 1,570 | 2,342 |
| 20-Day Average Volume | 4,001,600 | 10,940,626 | 3,268,954 | 2,168,319 | 6,178,432 |
| Previous Close | 0.1295 | 48.51 | 103.86 | 265.51 | 67.75 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.3831 | 51.38 | 105.54 | 273.88 | 70.95 |
| 20-Day Raw Stochastic | 0.67% | 8.81% | 30.81% | 6.46% | 1.80% |
| 20-Day Relative Strength | 25.80% | 37.92% | 49.83% | 39.14% | 31.67% |
| Weighted Alpha | -91.75 | -29.40 | -18.87 | +6.00 | -22.77 |
| Today's Opinion | 100% Sell | 56% Sell | 72% Buy | 40% Sell | 100% Sell |
| Previous Opinion | 100% Sell | 56% Sell | 72% Buy | 40% Sell | 100% Sell |
| Last Month's Opinion | 72% Sell | 8% Sell | 40% Buy | 8% Sell | 72% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -70.00% since 03/28/23 | -5.66% since 04/09/24 | -7.87% since 04/09/24 | -1.65% since 04/09/24 | -3.15% since 04/09/24 |
| Low | 0.0532 on 04/04/23 | 48.12 on 04/15/24 | 102.30 on 04/15/24 | 264.35 on 04/15/24 | 67.62 on 04/12/24 |
| High | 0.2100 on 03/30/23 | 51.28 on 04/10/24 | 110.29 on 04/10/24 | 273.00 on 04/11/24 | 69.76 on 04/10/24 |
| 1-Month | |||||
| %Chg | -89.75% since 03/03/23 | -6.99% since 03/15/24 | -0.99% since 03/15/24 | -1.10% since 03/15/24 | -8.07% since 03/15/24 |
| Low | 0.0532 on 04/04/23 | 48.12 on 04/15/24 | 97.00 on 04/03/24 | 264.35 on 04/15/24 | 67.62 on 04/12/24 |
| High | 0.6200 on 03/17/23 | 54.47 on 03/28/24 | 115.89 on 04/09/24 | 288.57 on 03/28/24 | 74.28 on 03/21/24 |
| 3-Month | |||||
| %Chg | -88.93% since 01/04/23 | -2.64% since 01/16/24 | +0.65% since 01/16/24 | -12.38% since 01/16/24 | -21.22% since 01/16/24 |
| Low | 0.0532 on 04/04/23 | 47.58 on 02/06/24 | 84.06 on 02/13/24 | 264.35 on 04/15/24 | 67.62 on 04/12/24 |
| High | 0.9378 on 02/03/23 | 55.03 on 03/13/24 | 115.89 on 04/09/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 |
| 6-Month | |||||
| %Chg | -93.16% since 10/04/22 | -14.85% since 10/16/23 | +11.83% since 10/16/23 | -7.31% since 10/16/23 | -14.47% since 10/16/23 |
| Low | 0.0532 on 04/04/23 | 47.58 on 02/06/24 | 62.55 on 11/02/23 | 249.70 on 10/31/23 | 67.62 on 04/12/24 |
| High | 0.9600 on 11/02/22 | 57.65 on 10/17/23 | 115.97 on 01/08/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,099 | 98,318,080 | 39,765,916 | 142,291,856 | 84,353,968 |
| Shares Outstanding, K | 36,830 | 2,026,759 | 382,880 | 535,919 | 1,245,077 |
| Annual Sales | 22,940,000 | 45,006,000,000 | 6,848,000,000 | 28,190,000,000 | 27,116,000,000 |
| Annual Net Income | -37,160,000 | 8,025,000,000 | -4,714,000,000 | 6,717,000,000 | 5,665,000,000 |
| Last Quarter Sales | 28,000 | 11,477,000,000 | 2,811,000,000 | 8,196,000,000 | 7,114,000,000 |
| Last Quarter Net Income | -19,278,000 | 1,762,000,000 | 217,000,000 | 767,000,000 | 1,429,000,000 |
| 60-Month Beta | 3.71 | 0.39 | 1.62 | 0.58 | 0.19 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.77 on 11/03/22 | 1.70 on 02/02/24 | 0.55 on 02/22/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 |
| Latest Earnings Date | 05/04/23 | 04/25/24 | 05/02/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 |
| Next Ex-Dividends Date | N/A | 04/04/24 | N/A | 05/16/24 | 03/14/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 6.44 | 0.00 | 14.33 | 10.13 |